Researchers have demonstrated a previously undefined role of histone deacetylase 11 (HDAC11), in regulating T-cell effector functions.
Browsing: Disease Area > Hematologic
In this interview find out from Susan Paskar, a bone marrow transplant clinical nurse specialist in hemato-oncology, about the work Antony Nolan does and how the management of hematologic malignancies has advanced over the last few years.
Editor, Jade Parker recently spoke with George Vassiliou from the Wellcome Trust Sanger Institute (Cambridge, UK) about how his team are studying the genes and genetic pathways involved in the development of blood cancers.
Listen to this exclusive interview with Peter Stern (University of Manchester, UK) to discover more about chemotherapy resistance in acute lymphoblastic leukemia and novel strategies to overcome it.
A group of researchers have uncovered a link between chemo-resistance in pediatric acute lymphoblastic leukaemia and the protein 5T4; early-testing indicates that targeting the protein could help improve treatment outcomes.
In this interview find out about Anthony Nolan’s research strategy, breakthroughs that have aided the advancement of stem cell transplantation, how third-generation sequencing for HLA typing may improve donor-recipient matching and the direction that Alejandro Madrigal envisions Anthony Nolan’s research will take in the coming years.
A study from leading charity Anthony Nolan highlights the roles donor age and virus status have in patient survival following transplantation.
Pat Garcia-Gonzalez and Ann Kim Novakowski from The Max Foundation speak to Sebastian Dennis-Beron, commissioning editor at Future Medicine, for Oncology Central.
This editorial provides and insight into proton beam therapy as a promising treatment for pediatric cancers, it covers the cost effectiveness, clinical concerns and future prospective of the therapy.
Scientists report long-term follow up studies from a clinical trial involving patients with previously untreatable forms of chronic lymphocytic leukemia.